Milbank LLP is advising Werfen S.A. in connection with its definitive agreement with the holding company of Immucor, Inc. (“Immucor”) to acquire Immucor from TPG for approximately USD $2 billion. The transaction is expected to close in the first half of 2023, subject to regulatory approvals and the satisfaction of other customary closing conditions.
Immucor is a privately-held corporation with a strong global presence in transfusion and transplant in vitro diagnostics, headquartered in Norcross, Georgia, USA. Werfen is a worldwide developer, manufacturer and distributor of Specialized Diagnostic instruments, related reagents, automation workcells and data management solutions for use primarily in hospitals and independent clinical laboratories.
“We are pleased to be working with Werfen on this landmark transaction, which fits squarely with Werfen’s long-term vision and strategy and adds to our great number of M&A transactions in 2022,” said Milbank partner Tim Peterson. Milbank partner Francisco Nuñez added, “We are proud to be representing a world-class healthcare company like Werfen as it expands in the United States and globally and we look forward to continuing to work together.”
The Milbank deal team was led by partners Tim Peterson, Francisco Nuñez and Neil Whoriskey with the support of Global Corporate associates Alex Wang, Zachary Young and Alan Wen. The team also included Finance partners Michael Bellucci, Miko Bradford, John Goldfinch and Carlos Albarracin, associates Emily Rutcofsky, Varun Natteri Mangadu, Gabrielle Paolini, Giulia Petragnani Gelosi, Christopher Smith, Pranahita Srinivas* and Adrian Kwok; Global Corporate partner Markus Muhs, special counsel John Garces, and associates David Schwenneker, Anthony Zurcher, Jin Jeon and Jana Kasakow; Tax partner Max Goodman and associate Michael Rivkin; Executive Compensation partner Mike Shah and associates Kelly Bartley and Jon Sorger; Antitrust partners Fiona Schaeffer, Alexander Rinne and Andrea Hamilton, special counsel Andrew Wellin and associates Nils Bremer, Stefanie Gschoßmann, Jan Maas and Mariella Montplaisir Bazan; Global Risk & National Security partner John Beahn and special counsel Dana Zelman; Litigation partner Dan Perry, of counsel Jane Hanson and associate Matthew Grier; Real Estate associate Kevin Mu; and Environmental partner Matt Ahrens and associate Allison Sloto.
